4 Struggling Stocks With “Harmless” Pullbacks

Core Insights - The article draws a parallel between certain stocks and snakes, highlighting that some stocks may appear risky but are actually safe investments, akin to king snakes mimicking coral snakes [1][3]. Stock Analysis - CRISPR Therapeutics AG (NASDAQ:CRSP): The stock has decreased by 21% this quarter and 23% from its annual high of $78.48. However, it has maintained its prior low of around $51 and its 200-day moving average, indicating potential support. The stock only fell 0.7% post-earnings after a narrower-than-expected loss, and its experimental cholesterol treatment shows promise. The 14-day Relative Strength Index (RSI) is at 30, suggesting it may be a good buying opportunity [5]. - Crocs Inc (NASDAQ:CROX): The stock held its prior low of $73, and despite current unattractiveness, there are optimistic signs following earnings with a top-line beat and price-target hikes. Options are affordably priced, making it a potential buy for investors looking for value [7]. - Palantir Technologies Inc (NASDAQ:PLTR): The stock is currently facing challenges, with a middling RSI and support at the 100-day moving average. There are concerns about a potential double top formation, and it is viewed as a target due to AI valuation concerns [9]. - AppLovin Corp (NASDAQ:APP): The stock briefly breached its prior lows at $545 but quickly recovered, indicating chart support. While it is not considered oversold, the 80-day trendline is providing assistance, and $500 was a significant peak earlier in the year [11]. Volatility Insights - All four stocks mentioned have implied volatilities at modest-to-low levels, which is advantageous for options traders looking for stocks experiencing a post-earnings volatility crush [13]. Value Trap Consideration - The article also mentions the concept of value traps, referring to stocks that have performed well but may not have reached their lowest point yet, indicating potential risks for investors [14].